Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine versus methadone + diazepam + haloperidol for severe chronic cancer pain in the emergency ward
IRCT20141209020258N93Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cancer pain comparing Methadone + haloperidol + diazepam with Morphine (2 arms). Primary endpoints: Patient satisfaction, Pain and 1 more. Started Jun 2018; status: completed.
02
Drugs
morphinemethadonediazepamhaloperidol
03
Conditions
cancer pain
Beyond the preview
Go deeper on IRCT20141209020258N93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N93.